Saturday 17 October 2026 Export STLN’s income statement to Excel — free account

Starling Oncology, Inc.

Starling Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.7 million, up 27.8% from fiscal 2024. In the quarter to June 2026, revenue grew 34.6%, EPS grew 46.7%, free cash flow grew 196.7% and total debt rose 6.46%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

6.43 0.48 −6.95%

Follow STLN

Alert me

Market cap: $690.9M
P/E: 0.0×
Fwd P/E: −32.5×
Dividend yield: —
F-score: 4/9
Altman Z: 1.42
Beneish M: −3.39
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.95	0.57	0.65	0.74
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	46.86	(141.10)	101.73	(26.93)
P/B ratio Full definition →	0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	1.02	0.66	0.74	0.84
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	1,824.43	(16.55)	(15.17)	(16.46)
EV/FCF Full definition →	(182.11)	(14.03)	(13.42)	(14.13)
Quick Ratio Full definition →	1.14	1.13	1.31	1.34
Current Ratio Full definition →	1.36	1.47	1.59	1.68
Net Debt/EBITDA Full definition →	(25.47)	(13.11)	(10.77)	(9.41)
Debt/Assets Full definition →	44.81%	46.73%	47.01%	46.57%
Debt/Equity Full definition →	(3.21)	(4.83)	(4.92)	(6.21)
Asset Turnover Full definition →	3.47	3.29	2.98	2.69
Operating CF/Net income Full definition →	(1.22)	0.89	(0.43)	0.77
Capex/Depreciation Full definition →	(0.29)	(0.37)	(0.37)	(0.21)
Interest Coverage Full definition →	(2.48)	(3.37)	(3.60)	(4.19)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	18.57%	19.13%	19.75%	18.49%
Intangible Assets out of Total Assets Full definition →	0.09	0.10	0.11	0.12
Share Based Compensation of Revenue Full definition →	0.66%	1.14%	0.93%	0.75%
Graham Net Nets Full definition →	(0.13)	(0.22)	(0.21)	(0.19)
Graham Number Full definition →	1.28	1.15	1.46	1.35
Earnings Yield Full definition →	(5.52%)	(12.05%)	(15.73%)	(18.34%)
Free Cash Flow Yield Full definition →	(0.59%)	(8.23%)	(8.45%)	(8.09%)
Revenue per Share Full definition →	1.57	1.45	1.54	1.40
Operating CF per Share Full definition →	0.12	(0.02)	0.04	(0.13)
Capex per Share Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →	0.11	(0.03)	0.02	(0.14)
Cash per Share Full definition →	0.40	0.30	0.36	0.28
Shareholders Equity per Share Full definition →	(0.24)	(0.16)	(0.17)	(0.13)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	(0.24)	(0.16)	(0.17)	(0.13)
Free Cash Flow Full definition →	11.03	(3.26)	2.17	(13.23)
Working Capital Full definition →	34.05	37.51	41.79	44.51
Capital Expenditures Full definition →	(0.91)	(1.04)	(1.06)	(0.60)
Net Current Asset Value Full definition →	(74.16)	(67.65)	(67.63)	(65.80)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.01	0.01	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	61.32	54.56	54.00	57.42
Average Payables Full definition →	47.61	38.47	33.75	30.10
Average Inventory Full definition →	17.90	18.30	13.46	14.49
Average Assets Full definition →	169.02	166.12	168.69	171.40
Average Common Equity Full definition →	(16.95)	(5.61)	(6.07)	1.60

Fold the line items

Columns are period end dates

Stockrow Weekly